EP4271654A1 - Ultraschallunterstütztes thermophiles aerobes membrandestillationsbioreaktorsystem (sono-mdbr) und zur behandlung von krankenhausabwasser entwickeltes verfahren - Google Patents
Ultraschallunterstütztes thermophiles aerobes membrandestillationsbioreaktorsystem (sono-mdbr) und zur behandlung von krankenhausabwasser entwickeltes verfahrenInfo
- Publication number
- EP4271654A1 EP4271654A1 EP21916051.2A EP21916051A EP4271654A1 EP 4271654 A1 EP4271654 A1 EP 4271654A1 EP 21916051 A EP21916051 A EP 21916051A EP 4271654 A1 EP4271654 A1 EP 4271654A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- reactor
- treatment
- mdbr
- sono
- hospital wastewater
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 53
- 239000002351 wastewater Substances 0.000 title claims abstract description 52
- 238000011282 treatment Methods 0.000 title claims abstract description 48
- 239000012528 membrane Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000004821 distillation Methods 0.000 title claims abstract description 12
- 239000012466 permeate Substances 0.000 claims description 27
- 239000010802 sludge Substances 0.000 claims description 21
- 244000005700 microbiome Species 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000523 sample Substances 0.000 claims description 10
- 230000002572 peristaltic effect Effects 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 230000004907 flux Effects 0.000 claims description 3
- 238000011109 contamination Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 239000003344 environmental pollutant Substances 0.000 description 19
- 231100000719 pollutant Toxicity 0.000 description 19
- 238000012554 master batch record Methods 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 10
- 238000004065 wastewater treatment Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 238000006065 biodegradation reaction Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000010840 domestic wastewater Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000009303 advanced oxidation process reaction Methods 0.000 description 3
- 230000033558 biomineral tissue development Effects 0.000 description 3
- 230000008260 defense mechanism Effects 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000001728 nano-filtration Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000000193 iodinated contrast media Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002101 nanobubble Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000002918 waste heat Substances 0.000 description 2
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001135265 Cronobacter sakazakii Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000017168 chlorine Nutrition 0.000 description 1
- 125000001309 chloro group Chemical class Cl* 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 231100000049 endocrine disruptor Toxicity 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003254 gasoline additive Substances 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 244000000013 helminth Species 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000006385 ozonation reaction Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000002957 persistent organic pollutant Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F9/00—Multistage treatment of water, waste water or sewage
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/36—Pervaporation; Membrane distillation; Liquid permeation
- B01D61/364—Membrane distillation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/36—Pervaporation; Membrane distillation; Liquid permeation
- B01D61/368—Accessories; Auxiliary operations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/26—Further operations combined with membrane separation processes
- B01D2311/2611—Irradiation
- B01D2311/2615—Application of high-frequency electromagnetic fields or microwave irradiation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/34—Treatment of water, waste water, or sewage with mechanical oscillations
- C02F1/36—Treatment of water, waste water, or sewage with mechanical oscillations ultrasonic vibrations
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
- C02F1/447—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by membrane distillation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/003—Wastewater from hospitals, laboratories and the like, heavily contaminated by pathogenic microorganisms
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/005—Processes using a programmable logic controller [PLC]
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/02—Temperature
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/06—Controlling or monitoring parameters in water treatment pH
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/40—Liquid flow rate
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/42—Liquid level
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/02—Aerobic processes
- C02F3/12—Activated sludge processes
Definitions
- the invention relates to an ultrasound (US) assisted thermophilic aerobic membrane distillation bioreactor (sono-MDBR) system and method developed for the treatment of hospital wastewater.
- US ultrasound
- sono-MDBR thermophilic aerobic membrane distillation bioreactor
- Water recovery is very important in terms of both clean water scarcity and environmental pollution. Salts, nutrients (such as nitrogen, phosphorus), pathogens and micropollutants (MP) must be removed from the wastewater for a reliable water recycling.
- micropollutants are the main source of the problem, as conventional wastewater treatment plants are not specifically designed to treat these pollutants. Micropollutants may be present in wastewaters at concentrations of pg/L or lower. If they are not adequately removed, most micropollutants can cause negative effects on human health and the ecosystem, such as the formation of resistant bacteria. Therefore, these pollutants threaten the receiving environment where they are discharged as well as the reuse of wastewater.
- micropollutant consist of pollutants such as surfactants, pharmaceuticals and personal care products, endocrine disruptors, unregistered drugs, gasoline additives, etc.
- pollutants such as surfactants, pharmaceuticals and personal care products, endocrine disruptors, unregistered drugs, gasoline additives, etc.
- the consumption of pharmaceuticals in these pollutants is increasing year by year. Only a certain part of these drugs is metabolized after use. The nonmetabolized part is usually excreted from the body through the urine.
- Hospital wastewater one of the most important sources of these pollutants, includes recalcitrant and toxic micropollutants resulting from metabolite products of drugs, chemicals, heavy metals, disinfectants and sterilizers, specific detergents of endoscopic and other devices, radioactive tracers and iodinated contrast media (ICM).
- ICM iodinated contrast media
- Disinfectants are used for disinfection of floors, device and skin disinfection and food preparation in hospitals. Chlorines containing recalcitrant such as alcohol, aldehyde and even chlorophenol are used as disinfectants.
- Chlorines containing recalcitrant such as alcohol, aldehyde and even chlorophenol are used as disinfectants.
- microbial pollutants such as bacteria, viruses, and helminths.
- micropollutant removal with advanced oxidation processes such as fenton, UV, ozone. These processes are generally applied to the biological treatment outlet in hospital wastewater treatment, but when applied on their own, the full mineralization efficiency is fairly low. Intermediate products formed in partial degradation may be more toxic than the parent compound or have the same properties as the parent compound.
- Integrated advanced oxidation processes such as Ch/Fenton, O3/H2O2, O3/UV, Ch/Photo- Fenton can be used for the complete mineralization of micropollutants, but high operating and initial investment costs arise due to these methods.
- MBR Membrane bioreactors
- MF microfiltration
- UF ultrafiltration
- MBRs membrane bioreactors
- MF microfiltration
- UF ultrafiltration
- MBRs are generally operated at high biomass concentrations (10-20 g/L) and high sludge ages (10-30 days), and consequently produce better quality effluent and less waste sludge compared to the conventional activated sludge system.
- MBRs for the same treatment capacity require less space and volume than the conventional active sludge system.
- the hydraulic residence time (HRT) may be shorter especially in MBRs operated at high MLSS (Mixed Liquor Suspended Solids) concentrations. Therefore, advanced treatment methods such as reverse osmosis (TO), nanofiltration (NF), UV oxidation or ozonation are generally recommended for the removal of micropollutants in MBR effluent. Even though quality water can be obtained with these multiple treatment systems, it overshadows the advantage to be obtained by re-using wastewater due to the high investment and operating costs and the need for more construction areas.
- TO reverse osmosis
- NF nanofiltration
- UV oxidation or ozonation UV oxidation or ozonation
- HR-MBR high retention capacity MBR
- NF-MBR MMR using NF membrane instead of MF/UF membrane
- OMBR MR using advanced osmosis membrane instead of MF/UF membrane
- MDBR MDBR using distillation membrane instead of MF membrane
- Thermophilic wastewater treatment is the treatment of wastewater consisting of different sources by increasing the temperature above 45°C and to a maximum of 70°C.
- Thermophilic aerobic wastewater treatment has some advantages compared to conventional systems such as more degeneration rate, inactivation of pathogens, low sludge production and process stability. Thus, the main cost will decrease as the retention time required for treatment will be reduced. Meanwhile, thermophilic treatment is stable in case of deterioration of conditions. Another advantage of thermophilic bacteria is that they destroy the microorganisms causing the disease at temperatures of 55°C and above. Some pollutants, which are slow biodegradable, can also be broken down more rapidly with thermophilic treatment. The rate of degeneration of micropollutants, which are examples of these pollutants, increases with thermophilic treatment.
- Thermophilic systems in particular, can be applied for wastewaters with high pollution load and low flow rate, wastewaters with high salinity or containing hazardous compounds.
- Thermophilic treatment of high strength and/or high temperature wastewaters such as domestic paper, chicken slaughterhouse, beer, synthetic, fruit industry has been investigated, and studies have shown that it is effective even in the treatment of high strength landfill wastewaters.
- This technology has started to be widely used for the treatment of various types of wastewater in recent years.
- the permeate quality in MDBR is of TO permeate quality and is independent of biological activity. Since the continuity of the permeate quality can be ensured even in case of low bioactivity in the reactor, it is resistant to shock loading and operating problems.
- the permeate quality obtained in a single system with MDBR is the same as the conventional activated sludge system + MF + TO or the effluent quality obtained by multiple systems such as MBR + TO.
- the time required for commissioning is much shorter than the classical MBR since the quality of the permeate in MDBR is not dependent on the bioactivity in the reactor.
- the pollutants, which are slow biodegradable and recalcitrant, stay in the bioreactor for a longer period of time, thereby it is possible to break them down.
- MDBR is a system operated under atmospheric conditions, its dependence on electrical energy is less than pressure systems. The need for thermal heat can be provided from waste heat or solar energy.
- Non-volatile compounds are completely retained, while volatile compounds can pass through the membrane in the membrane distillation (MD) process.
- MDBR membrane distillation
- biological degradation can contribute to the removal of volatile compounds in wastewater.
- Table 1 The main differences between MDBR and conventional MF/UF-MBRs are summarized in Table 1.
- An important point to note is that non-volatile compounds such as salt are kept in the process and accumulated until they are disposed of with waste sludge.
- US ultrasound
- US increases fluid mixture and mass transport.
- enzymes accelerate the transport of nutrients to their active points and the removal of microbial waste products from these active points.
- Short-term application periods damage the cell at a level that it can tolerate and increase the membrane permeability of the cell.
- US is applied continuously, cell destruction increases and bioactivity decreases.
- the increase in bioactivity with short-term application periods is due to the activation of defense mechanisms because microorganisms are exposed to US. Therefore, since different microorganisms will have different defense mechanisms, they will react differently to the US application of the same frequency and power.
- the China patent document CN103304109A which is the state of the art, mentions the treatment of hospital wastewater by using biological treatment and membrane.
- the submerged UF membrane was preferred to make a solid liquid separation and no application was included to increase bioactivity in this patent.
- Japan patent document JP5097024B2 which is the state of the art, which aims to create bubbles of different sizes and to treat with nanobubbles in particular. US was also used to produce the nanobubble, which is the main purpose of the study. However, there is no purpose that increases bioactivity in any biological treatment even though the objective of the study is not the treatment of hospital wastewater.
- the object of the present invention is to realize the Sono-MDBR system and method developed for the treatment of hospital wastewater.
- Another object of this invention is to realize the Sono-MDBR system and method, which performs well for industries producing recalcitrant and toxic wastewater, such as hospital wastewater, and where the effluent can be used directly (without additional treatment).
- FIG 1 A schematic view of the US assisted thermophilic aerobic membrane distillation bioreactor (MDBR) system of the invention.
- MDBR thermophilic aerobic membrane distillation bioreactor
- the present invention relates to the Sono-MDBR system developed for the treatment of hospital wastewater and comprises the following elements:
- thermophilic aerobic bioculture and covered with a heat jacket
- Air compressor (6) connected to the diffuser (5) and providing the air requirement of the system
- thermophilic aerobic bioculture and permeate water in the reactor (1) in contact with thermophilic aerobic bioculture and permeate water in the reactor (1), - Heater (11) connected with the reactor (1) and providing the heating of the reactor (1) to the temperature required for the thermophilic conditions and MD,
- the present invention relates to the Sono-MDBR method developed for the treatment of hospital wastewater and comprises the following steps;
- thermophilic aerobic mixed culture is located
- thermophilic mixed microorganism culture in the reactor (1) in order to increase bioactivity
- US generator (4) with 20 kHz frequency is used in which hospital wastewater is treated with Sono-MDBR system in the system of the invention.
- Ultrasound (US) is applied to the thermophilic mixed microorganism culture in MDBR at a power density of 5.4 W/L for 12.5 minutes in 24 hour periods in order to increase bioactivity in the system.
- a "silent" (non-US) control operating under the same operating conditions as sono-MDBR was operated for MDBR comparison.
- the US is applied to thermophilic aerobic bioculture with the transducer (3), which is flanged to the base of the reactor (1) in the system of the invention.
- the reactor (1) is made of stainless steel material so that its connection with the transducer (3) is smooth and the cavitation does not damage the walls.
- the system consists of the main bioreactor (1), the submerged direct contact distillation membrane module (2), the balancing tank (7), the permeate collection tank (7), the PLC control unit (13) and the ventilation system.
- MD module (2) in MDBR was placed in the bioreactor (1), leaving it outside the cavitation area and paying attention to the sufficient air stripping.
- Air is supplied to the system with an air compressor (6) for both oxygen demand and suspension of the aerobic culture in the reactor (1) and for controlling the pollution that will occur on the surface of the submerged distillation membrane.
- the temperature, conductivity, pH, dissolved oxygen concentration of the thermophilic active sludge, and the conductivity and temperature of the permeate are measured with probes (10) and continuously monitored with PLC (13).
- the permeate flow is circulated via the peristaltic pump (9) from the submerged direct contact MD module (2) to the permeate collection tank (8) and then to the cooler (12).
- the reactor (1) was surrounded by a heat jacket and kept at a constant temperature with the help of a heater (11) in order to keep the operating temperature (55.5 ⁇ 1°C) under control.
- the temperature of the permeate circulated on the other side of the membrane is kept constant at 19.5 ⁇ 1°C.
- thermophilic active sludge is in direct contact with the membrane surface.
- the distillation membrane was placed far enough away that it would not be affected by the ultrasound applied in thermophilic active sludge cavitation and microbes. Otherwise, there is a possibility of wetting and/or damage to the membrane.
- Raw hospital wastewater is fed to the reactor (1) automatically by the PLC (13) with level control and with the help of the peristaltic pump (9).
- the system and method of the invention is a study in which ultrasound is applied to MDBR and ultrasound is applied to classical aerobic thermophilic active sludge whose bioactivity (growth rate, endogenous respiration, enzymatic activity, etc.) is different from mesophilic aerobic active sludge.
- Both hospital wastewater and micropollutants are treated with ultrasound (US) assisted thermophilic MDBR thanks to the system and method of the invention.
- the treatment of hospital wastewater was 5 carried out with the sono-MDBR system having important wastewater treatment advantages as mentioned above, which is made as a compact reactor by combining MD, thermophilic biological treatment and ultrasound.
- COD Chemical oxygen demand
- BOD Biochemical oxygen demand
- AOX Absorbable organic halogens
- chloride and orthophosphate a removal efficiency over 99.9% was obtained, while in sono-MDBR and control-MDBR a 0 TOC (Total organic carbon) removal efficiency of 99.63% and 99.59% were achieved, respectively when the pollutant concentrations in the effluent are examined.
Landscapes
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Organic Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Physical Water Treatments (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2020/22273A TR202022273A2 (tr) | 2020-12-29 | 2020-12-29 | Hastane atik-sularinin aritimi i̇çi̇n geli̇şti̇ri̇lmi̇ş ultrases destekli̇ termofi̇li̇k aerobi̇k membran di̇sti̇lasyon bi̇yoreaktör (sono-mdbr) si̇stemi̇ ve yöntemi̇ |
PCT/TR2021/051526 WO2022146373A1 (en) | 2020-12-29 | 2021-12-27 | Ultrasound assisted thermophilic aerobic membrane distillation bioreactor (sono-mdbr) system and method developed for the treatment of hospital wastewater |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4271654A1 true EP4271654A1 (de) | 2023-11-08 |
Family
ID=82260999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21916051.2A Pending EP4271654A1 (de) | 2020-12-29 | 2021-12-27 | Ultraschallunterstütztes thermophiles aerobes membrandestillationsbioreaktorsystem (sono-mdbr) und zur behandlung von krankenhausabwasser entwickeltes verfahren |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4271654A1 (de) |
TR (1) | TR202022273A2 (de) |
WO (1) | WO2022146373A1 (de) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10252544A1 (de) * | 2002-11-08 | 2004-05-27 | Kahler, Papst & Schmidt Patentverwertungs Gesbr | Verfahren und Anlage zum Reinigen von Abwässern od.dgl. Flüssigkeiten |
CN101659495A (zh) * | 2008-08-29 | 2010-03-03 | 北京清大国华环保科技有限公司 | 一种膜蒸馏生物反应器的装置与方法 |
US10799835B2 (en) * | 2015-01-16 | 2020-10-13 | Pure Blue Tech Inc. | Methods and apparatuses for reducing membrane fouling, scaling, and concentration polarization using ultrasound wave energy (USWE) |
US10828606B2 (en) * | 2017-10-25 | 2020-11-10 | New Jersey Institute Of Technology | Radiative treatment of liquids in desalination and other membrane processes |
CN108298777A (zh) * | 2018-04-17 | 2018-07-20 | 杨孝耀 | 一种环绕式多层污水处理装置及方法 |
-
2020
- 2020-12-29 TR TR2020/22273A patent/TR202022273A2/tr unknown
-
2021
- 2021-12-27 EP EP21916051.2A patent/EP4271654A1/de active Pending
- 2021-12-27 WO PCT/TR2021/051526 patent/WO2022146373A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TR202022273A2 (tr) | 2022-07-21 |
WO2022146373A1 (en) | 2022-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dehghani | Effectiveness of ultrasound on the destruction of E. coli | |
JP5746750B2 (ja) | 船舶バラスト水処理方法及びシステム | |
TWI594957B (zh) | 移除難分解之有機污染物的方法 | |
Almukdad et al. | Unlocking the application potential of electrocoagulation process through hybrid processes | |
KR20160031562A (ko) | 부유식 생물 반응기 시스템 | |
JP2002306930A (ja) | 水処理方法および水処理装置 | |
KR20090105113A (ko) | 선박용 생물화학식 오수처리장치 | |
US20110084031A1 (en) | Treatment of a waste stream through production and utilization of oxyhydrogen gas | |
JP5066487B2 (ja) | 過酸化水素含有有機性水の処理方法および処理装置 | |
JP2016117064A (ja) | 汚水処理装置及びこれを用いた汚水処理方法 | |
Rodríguez et al. | Performance of bench-scale membrane bioreactor under real work conditions using pure oxygen: viscosity and oxygen transfer analysis | |
JP2014000495A (ja) | 汚水処理装置及びこれを用いた汚水処理方法 | |
Al-Malack | Performance of an immersed membrane bioreactor (IMBR) | |
EP4271654A1 (de) | Ultraschallunterstütztes thermophiles aerobes membrandestillationsbioreaktorsystem (sono-mdbr) und zur behandlung von krankenhausabwasser entwickeltes verfahren | |
Hosseinzadeh et al. | A study on membrane bioreactor for water reuse from the effluent of industrial town wastewater treatment plant | |
Aidan et al. | Particulates and bacteria removal by ceramic microfiltration, UV photolysis, and their combination | |
JP5269331B2 (ja) | 廃水処理装置 | |
Poyatos et al. | Effect of the mixed liquor suspended solid on permeate in a membrane bioreactor system applied for the treatment of sewage mixed with wastewater of the milk from the dairy industry | |
KR20030097075A (ko) | 생물막활성탄과 마이크로필터모듈을 이용한 오·폐수고도처리장치 | |
Li et al. | Optimization of the operating parameters for online ultrasonic on controlling membrane fouling in SMBR | |
Munshi et al. | Impact of UV irradiation on controlling biofouling problems in NF-SWRO desalination process | |
Özan et al. | Treatment of domestic wastewater by membrane bioreactor system (MBR) | |
Ujang et al. | Comparative study on microbial removal in immersed membrane filtration (IMF) with and without powdered activated carbon (PAC) | |
JP2000204629A (ja) | 自己完結型水洗式トイレ | |
Meyo | Treatment of poultry slaughterhouse wastewater using a pretreatment stage, an expanded granular sludge bed reactor coupled with a membrane bioreactor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230724 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |